Your browser doesn't support javascript.
loading
The accumulation of advanced glycation end-products in a schizophrenic patient with a glyoxalase 1 frameshift mutation: An autopsy study.
Torii, Youta; Iritani, Shuji; Sekiguchi, Hirotaka; Habuchi, Chikako; Fujishiro, Hiroshige; Kushima, Itaru; Kawakami, Ito; Itokawa, Masanari; Arai, Makoto; Hayashida, Shotaro; Masaki, Katsuhisa; Kira, Jun-Ichi; Kawashima, Kunihiro; Ozaki, Norio.
Afiliação
  • Torii Y; Department of Psychiatry, Graduate School of Medicine, Nagoya University, 65 Tsurumai, Showa-ku, Nagoya, Aichi 466-8550, Japan; Department of Psychiatry, Moriyama General Psychiatric Hospital, 11-50 Machikita, Moriyama-ku, Nagoya, Aichi 463-8570, Japan. Electronic address: youtat@med.nagoya-u.ac.jp.
  • Iritani S; Department of Psychiatry, Graduate School of Medicine, Nagoya University, 65 Tsurumai, Showa-ku, Nagoya, Aichi 466-8550, Japan. Electronic address: iritani@med.nagoya-u.ac.jp.
  • Sekiguchi H; Department of Psychiatry, Graduate School of Medicine, Nagoya University, 65 Tsurumai, Showa-ku, Nagoya, Aichi 466-8550, Japan.
  • Habuchi C; Department of Psychiatry, Graduate School of Medicine, Nagoya University, 65 Tsurumai, Showa-ku, Nagoya, Aichi 466-8550, Japan.
  • Fujishiro H; Department of Psychiatry, Graduate School of Medicine, Nagoya University, 65 Tsurumai, Showa-ku, Nagoya, Aichi 466-8550, Japan.
  • Kushima I; Department of Psychiatry, Graduate School of Medicine, Nagoya University, 65 Tsurumai, Showa-ku, Nagoya, Aichi 466-8550, Japan. Electronic address: kushima@med.nagoya-u.ac.jp.
  • Kawakami I; Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan. Electronic address: kawakami-it@igakuken.or.jp.
  • Itokawa M; Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan. Electronic address: itokawa-ms@igakuken.or.jp.
  • Arai M; Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan. Electronic address: arai-mk@igakuken.or.jp.
  • Hayashida S; Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. Electronic address: shoutaro@neuro.med.kyushu-u.ac.jp.
  • Masaki K; Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
  • Kira JI; Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. Electronic address: kira@neuro.med.kyushu-u.ac.jp.
  • Kawashima K; Department of Psychiatry, Moriyama General Psychiatric Hospital, 11-50 Machikita, Moriyama-ku, Nagoya, Aichi 463-8570, Japan. Electronic address: k-kawash@fujita-hu.ac.jp.
  • Ozaki N; Department of Psychiatry, Graduate School of Medicine, Nagoya University, 65 Tsurumai, Showa-ku, Nagoya, Aichi 466-8550, Japan. Electronic address: ozaki-n@med.nagoya-u.ac.jp.
Schizophr Res ; 223: 356-358, 2020 09.
Article em En | MEDLINE | ID: mdl-33008688

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Lactoilglutationa Liase Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Lactoilglutationa Liase Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article